This research investigates tularemia, a highly infectious disease caused by Francisella tularensis, and explores a weakened bacterial strain as a vaccine candidate. By studying how the pathogen evades immune defenses, the work aims to enable rapid immune recognition and response, improving protection against both natural infections and potential biothreats.

By stripping Salmonella of its molecular “effectors,” this research identifies interferon gamma as a key immune barrier preventing infection. A small set of SPV genes enables the bacterium to overcome this defense. Understanding these mechanisms reveals new targets for therapies against Salmonella, a major global health threat.